Johan Rutger Christenson

Président chez Aprea Personal AB

Profil

Johan Rutger Christenson is currently the Chairman of Aprea Personal AB and a Director of BeneChill, Inc., Cerenis Therapeutics, Inc., Healthcap 1999 GP AB, InCarda Therapeutics, Inc., Ancilla AB, Glionova AB, Healthcap Aero Holdings Gp, Healthcap Orx Holdings Gp AB, Trimb Holding AB, and a Partner at HealthCap AB. He previously held positions as Vice Chairman at Nexstim Oyj, Director at Medtronic CoreValve LLC, Director-Global Product at AstraZeneca AB, Director at Neuro3D SA, Director at Orexo AB, Director at Resistentia Pharmaceuticals AB, Director at Newron Sweden AB, Director at Oncopeptides AB, Director at TopoTarget UK Ltd., Non-Executive Director at ABIONYX Pharma SA, Director at Aprea Therapeutics AB, Director at Targovax Oy, Director at Algeta US LLC, Project Director at Astra Pain Control AB, and Principal at Odlander, Fredrikson & Co. AB. He also served as the Assistant Dean-Graduate School at Karolinska Institutet and Principal at SEB Venture Capital.
He holds a doctorate degree from Karolinska Institutet.

Postes actifs de Johan Rutger Christenson

Sociétés	Poste	Début
Ancilla AB	Directeur/Membre du Conseil	-
HealthCap AB	Private Equity Investor	01/01/2001
BeneChill, Inc.	Directeur/Membre du Conseil	21/07/2009
Trimb Holding AB	Directeur/Membre du Conseil	-
InCarda Therapeutics, Inc.	Directeur/Membre du Conseil	-
Glionova AB	Directeur/Membre du Conseil	-
Aprea Personal AB	Président	-
Healthcap Aero Holdings Gp	Directeur/Membre du Conseil	-

Anciens postes connus de Johan Rutger Christenson

Sociétés	Poste	Fin
FUSN PHAR	Directeur/Membre du Conseil	16/10/2023
░░░░░░░░░ ░░░░ ░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░